ScoreWhy is Edwards Lifesciences Corp. ?
1
High Management Efficiency with a high ROE of 22.80%
2
Company has a low Debt to Equity ratio (avg) at times
3
Flat results in Jun 25
- OPERATING CASH FLOW(Y) Lowest at USD 794.9 MM
- ROCE(HY) Lowest at 15.71%
- DEBTORS TURNOVER RATIO(HY) Lowest at 6.55 times
4
With ROE of 15.23%, it has a fair valuation with a 4.62 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 19.63%, its profits have fallen by -0.5% ; the PEG ratio of the company is 20.6
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Edwards Lifesciences Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Edwards Lifesciences Corp. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Edwards Lifesciences Corp.
15.61%
-0.10
24.08%
S&P 500
13.22%
0.64
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.64%
EBIT Growth (5y)
5.09%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.69
Tax Ratio
10.93%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
93.32%
ROCE (avg)
29.61%
ROE (avg)
22.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
4.62
EV to EBIT
29.18
EV to EBITDA
26.46
EV to Capital Employed
6.35
EV to Sales
7.86
PEG Ratio
20.62
Dividend Yield
NA
ROCE (Latest)
21.76%
ROE (Latest)
15.23%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
CASH AND EQV(HY)
Highest at USD 7,962.6 MM
NET SALES(Q)
Highest at USD 1,532.2 MM
OPERATING PROFIT(Q)
Highest at USD 458.1 MM
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD 794.9 MM
ROCE(HY)
Lowest at 15.71%
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.55 times
Here's what is working for Edwards Lifesciences Corp.
Net Sales
Highest at USD 1,532.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 458.1 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Cash and Eqv
Highest at USD 7,962.6 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Edwards Lifesciences Corp.
Operating Cash Flow
Lowest at USD 794.9 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Lowest at 6.55 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
